Displaying drugs 2326 - 2350 of 2778 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Quizartinib | 560.67 C29H32N6O4S |  | A FLT3 inhibitor used in combination with cytarabine and anthracycline to treat acute myeloid leukemia with FLT3 internal tandem duplication | Protein Kinase Inhibitors / Tyrosine Kinase Inhibitors |
| Oxatomide | 426.564 C27H30N4O |  | An antihistamine indicated in the treatment and prevention of allergic symptoms. | Piperazine Derivatives |
| Tazemetostat | 572.75 C34H44N4O4 |  | A methyltransferase inhibitor indicated to treat patients 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. | Methyltransferase Inhibitor |
| Nicoboxil | 223.272 C12H17NO3 |  | A medication used to treat acute back pain. | Drugs that are Mainly Renally Excreted / Pyridines |
| Resmetirom | 435.22 C17H12Cl2N6O4 |  | A thyroid hormone receptor-beta agonist used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis in adults. | BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / BSEP/ABCB11 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (weak) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B1/SLCO1B1 Substrates / OATP1B3 inhibitors / OATP1B3 substrates / Pyrimidines / Pyrimidinones / Thyroid hormone receptor-beta (THR-beta) agonist / UGT1A4 Inhibitors / UGT1A9 Inhibitors |
| Ozenoxacin | 363.417 C21H21N3O3 |  | A quinolone antibiotic used to treat impetigo caused by susceptible bacteria. | Topoisomerase Inhibitors |
| Isoxaflutole | 359.32 C15H12F3NO4S |  | Balance has been investigated for the treatment of Chronic Renal Failure and Peritoneal Membrane Disorder. | Membrane Proteins / Tumor Suppressor Proteins |
| Darolutamide | 398.85 C19H19ClN6O2 |  | An androgen receptor antagonist used for castration-resistant, non-metastatic prostate cancer and metastatic hormone-sensitive prostate cancer. | Antiandrogens |
| Lactitol | 344.3124 C12H24O11 |  | An orally administered osmotic laxative used to treat chronic idiopathic constipation. | Laxatives |
| Dihydralazine | 190.21 C8H10N6 |  | Dihydralazine is under investigation in clinical trial NCT00311974 (The Effect of Dihydralazine on Kidney Function and Hormones in Healthy Individuals). | Hydrazinophthalazine Derivatives / Hydrazinophthalazine Derivatives and Diuretics |
| Methylprednisone | 372.461 C22H28O5 |  | Methylprednisone has been used in trials studying the treatment of Leukemia, Rheumatoid Arthritis, Renal Transplantation, Kidney Transplantation, and Acute Lymphocytic Leukemia, among others. | Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A4 Substrates (strength unknown) / Cytochrome P-450 Substrates |
| Terizidone | 302.29 C14H14N4O4 |  | Terizidone has been used in trials studying the treatment of Tuberculosis, HIV Infections, Multidrug Resistant Tuberculosis, and Extensively-drug Resistant Tuberculosis. | Antiinfectives for Systemic Use / Antimycobacterials / Drugs for Treatment of Tuberculosis / Oxazoles |
| Silver | 107.8682 Ag |  | Indicated for the treatment of acne for topical use or the management of dental caries for dental use. | Silver Compounds |
| Pexidartinib | 417.82 C20H15ClF3N5 |  | An antitumor agent that is used for the treatment of rare disease tenosynovial giant cell tumors (TGCT) by inhibiting colony-stimulating factor 1 and its receptor. | Amines / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Cancer immunotherapy / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (weak) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Hepatotoxic Agents / Immunotherapy / Kinase Inhibitor / MATE 1 Inhibitors / MATE 2 Inhibitors / MATE inhibitors / Narrow Therapeutic Index Drugs / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / Organic Anion Transporting Polypeptide 2B1 Inhibitors / Protein Kinase Inhibitors / Pyridines / Tyrosine Kinase Inhibitors / UGT1A1 Inhibitors / UGT1A4 substrates |
| Silicon | 28.085 Si |  | A micronutrient indicated in nutritional products to treat or prevent silicon deficiencies. | Metalloids / Trace Elements |
| Oteseconazole | 527.403 C23H16F7N5O2 |  | An azole antifungal used to prevent recurrent vulvovaginal candidiasis in females who are not of reproductive potential. | Triazole and tetrazole derivatives |
| Parthenolide | 248.3175 C15H20O3 |  | Parthenolide has been used in trials studying the diagnostic of Allergic Contact Dermatitis. | Asteraceae / Standardized Chemical Allergen |
| Macimorelin | 474.565 C26H30N6O3 |  | A medication used to treat adult growth hormone deficiency. | Tests for Pituitary Function |
| Yttrium Y-90 | 89.9072 Y |  | Yttrium 90 has been investigated for the treatment of Colon Cancer and Colorectal Cancer. | Yttrium (90Y) Compounds |
| Lumefantrine co-artemether | 6116.74 C346H378Cl33N11O16 |  | Lumefantrine Co-Artemether (Riamet) has been investigated for the treatment of Malaria, Malaria, Falciparum, Malaria in Pregnancy, Uncomplicated Malaria, and Uncomplicated Knowlesi Malaria. Lumefantrine Co-Artemether is a tablet formulation of artemether... | Not Annotated |
| Biguanide | 101.113 C2H7N5 |  | Biguanide has been investigated for the treatment of Diabetes Mellitus. | Blood Glucose Lowering Agents / Guanidines |
| Amitriptylinoxide | 293.41 C20H23NO |  | A tricyclic antidepressant indicated in the treatment of depressive disorders. | Agents that produce hypertension / Agents that reduce seizure threshold / Neurotoxic agents / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome |
| Norflurane | 102.032 C2H2F4 |  | Norflurane is under investigation in clinical trial NCT01673061 (Vapocoolant Spray for Numbing Small Boils Before Incision and Drainage). | Aerosol Propellants / Anesthetics |
| Pentafluoropropane | 134.049 C3H3F5 |  | Pentafluoropropane is under investigation in clinical trial NCT01673061 (Vapocoolant Spray for Numbing Small Boils Before Incision and Drainage). | Hydrocarbons, Fluorinated / Hydrocarbons, Halogenated |
| Lusutrombopag | 591.54 C29H32Cl2N2O5S |  | A medication used to treat thrombocytopenia in patients with chronic liver disease scheduled to have a procedure. | Acids, Carbocyclic / BCRP/ABCG2 Substrates / Blood and Blood Forming Organs / Hemostatics / P-glycoprotein substrates / Sulfur Compounds / Thrombopoietin Receptor Agonist |
Displaying drugs 2326 - 2350 of 2778 in total